A phase 2 clinical trial using a new technology show it is possible to induce immune tolerance to gluten in individuals with celiac disease. After treatment with the technology, the patients were able to eat gluten with a substantial reduction in inflammation.
Read moreIn 2010-2016, many US transplant centers commonly accepted deceased donor kidneys with less desirable characteristics. The use of these organs varied widely across transplant centers, however, and differences were not fully explained by the size of waitlists or the availability of donor organs.
Read moreA new study points to the need for better antibody validation, and outlines a process that other labs can use to make sure the antibodies they work with function properly.
Read moreHow risky is travel in the US? It gets tricky. Despite a lot of research on the dangers of traffic injury and death, there's a lack of clarity on the role of the built environment (roadway designs and adjoining development) and its risk effects. Before we can know how risky a given built environment is, we have to know how many people are traveling there, and in many cases, for pedestrians and cyclists, this data is not available.
Read moreMany heart attack patients in China fail to receive beta-blockers which could prevent another event and save their life.
Read moreA new study found multiple effects on soils from exposure to manure from cows administered antibiotics, including alteration of the soil microbiome and ecosystem functions, soil respiration and elemental cycling.
Read moreIt is common knowledge that there is a connection between our genes and the risk of developing certain diseases. In a study on fruit flies, researchers have found that gene mapping can also be used to predict response to a given treatment. This knowledge is crucial for the development of personalized medicine.
Read moreA study of nearly 65,000 people suggests that devices coated with a drug called paclitaxel that are used for widening blocked arteries in legs and feet are safe and not linked to an increase in deaths — a finding that contradicts smaller studies that led to the FDA issuing a safety alert about the use of paclitaxel-coated stents and balloons for arterial revascularization in the lower limbs in January 2019.
Read morePET scanning can offer more precise selection of patients for neuroendocrine tumor therapy, allowing some patients to qualify who would otherwise have been ineligible, according to a new article.
Read moreThe discovery suggests new avenues for devising treatments and is a vital step toward finding a cure.
Read more